AXGN Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
69.7M
+13.5%
61.5M
+2.6%
59.9M
-0.3%
60.1M
+6.0%
56.7M
Cost of Revenue
19.1M
+24.8%
15.3M
-1.5%
15.5M
+10.0%
14.1M
-3.8%
14.6M
Gross Profit
50.7M
+9.7%
46.2M
+4.0%
44.4M
-3.4%
46.0M
+9.5%
42.0M
Operating Expenses
52.8M
+7.8%
49.0M
-9.5%
54.2M
+22.9%
44.1M
+9.3%
40.3M
R&D
8.6M
+14.3%
7.5M
-39.3%
12.4M
+63.6%
7.6M
+10.4%
6.9M
SG&A
44.2M
+6.6%
41.5M
-0.7%
41.8M
+14.5%
36.5M
+9.0%
33.5M
Operating Income
-2156000
+23.9%
-2832000
+71.0%
-9772000
-611.1%
1.9M
+14.4%
1.7M
EBITDA
-438000
+61.1%
-1127000
+86.0%
-8045000
-320.9%
3.6M
+7.3%
3.4M
Net Income
-1516000
+92.3%
-19584000
-48.9%
-13156000
-1958.2%
708.0K
+22.3%
579.0K
EPS (Basic)
$-0.03
+92.1%
$-0.38
-35.7%
$-0.28
-1500.0%
$0.02
+100.0%
$0.01
EPS (Diluted)
$-0.03
+92.1%
$-0.38
-22.6%
$-0.31
-3200.0%
$0.01
+0.0%
$0.01
Shares (Diluted)
53.3M
+3.4%
51.6M
+23.0%
41.9M
-14.6%
49.1M
+2.3%
48.0M
Axogen (AXGN) โ€” Financials